Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins.

Détails

ID Serval
serval:BIB_2486
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins.
Périodique
Journal of Lipid Research
Auteur(s)
Guerra R., Zhao B., Mooser V., Stafforini D., Johnston J.M., Cohen J.C.
ISSN
0022-2275 (Print)
ISSN-L
0022-2275
Statut éditorial
Publié
Date de publication
1997
Volume
38
Numéro
11
Pages
2281-2288
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, U.S. Gov't, P.H.S. Publication Status: ppublish
Résumé
Plasma platelet-activating factor acetylhydrolase (PAF-AH) is the enzyme that inactivates PAF (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine). We determined the relative contributions of genetic and environmental factors to variation in plasma PAF-AH activity in 240 individuals from 60 nuclear families. Regression of mean-offspring PAF-AH activity on the mid-parent value indicated that 62% of the variation in plasma PAF-AH activity was heritable. Spousal values were weakly negatively correlated, indicating that familial aggregation of PAF-AH activity is due to genetic rather than to environmental factors. Among normolipidemic individuals, plasma PAF-AH activity was strongly correlated with the plasma concentration of low density lipoprotein cholesterol (LDL-C), and treatment with lovastatin resulted in proportional decreases in plasma PAF-AH activity and LDL-C concentrations. To further elucidate the relationship between PAF-AH and plasma concentrations of LDL, plasma PAF-AH activity was measured in families with well-defined, monogenic disorders of LDL metabolism. Plasma PAF-AH activity cosegregated with plasma LDL-C concentrations in familial hypercholesterolemia, but not in familial hypobetalipoproteinemia. We speculate that the rate of removal of LDL from the circulation may determine the clearance rate of PAF-AH, thereby modulating the activity of PAF-AH in blood.
Mots-clé
1-Alkyl-2-acetylglycerophosphocholine Esterase, Age Factors, Cholesterol, LDL/blood, Female, Humans, Hyperlipidemia, Familial Combined/blood, Hyperlipidemia, Familial Combined/genetics, Hyperlipoproteinemia Type II/blood, Hyperlipoproteinemia Type II/genetics, Hyperlipoproteinemia Type IV/blood, Hyperlipoproteinemia Type IV/genetics, Hypobetalipoproteinemias/blood, Hypobetalipoproteinemias/genetics, Lipids/blood, Lipoproteins/blood, Lipoproteins, LDL/blood, Lovastatin/pharmacology, Male, Pedigree, Phospholipases A/blood, Phospholipases A/genetics, Regression Analysis, Sex Factors
Pubmed
Web of science
Création de la notice
19/11/2007 13:21
Dernière modification de la notice
03/03/2018 14:59
Données d'usage